Medical aesthetics, or medical aesthetics for short, is a cosmetic method of repairing and reshaping a person's appearance and various parts of the human body using traumatic or irreversible medical techniques such as drugs, surgery, and medical devices. Next, let's take a look at the top ten leading stocks in the medical aesthetic industry: 1. Introduction: Medical aesthetic industry leader, the first domestic enterprise to obtain the registration certificate of the relevant products and medical devices. Products:Solution injection products, gel injection products, facial implants, cosmetics. Valuation:Total market capitalization of 123.67 billion, P/E ratio of 23.31, TTM P/E ratio of 115.89, 66% below the historical time. Valuation is moderate. 2.Huaxi Biological Profile: the main products of hyaluronic acid and other biologically active substances and end products of biomedical materials. Products: hyaluronic acid raw materials (excluding derivatives), medical end products - injectable products, functional skin care products - disposable liquid. Valuation: Total market capitalization of 70.71 billion, P/E ratio of 11.64, TTM P/E ratio of 85.23, lower than the historical time 76%, valuation is low. 3.Aoyuan Meigu Introduction: China Plastic and Cosmetic Association certified 5A medical beauty institutions, the main business for the fiber new material business and medical beauty business. Products:Viscose series, real estate sales, medical beauty services. Valuation:Total market capitalization of 5.703 billion yuan, P/E ratio of 4.11, TTM P/E ratio is in the red, 27% lower than the historical time, valuation is high. 4.East China Medicine Introduction:Medical aesthetic industry specializing in
Focus on facial fillers, body contouring, buried wire, energy device and other non-surgical mainstream medical aesthetic products. Products: Chinese and Western medicines, medical devices, differentiated sodium hyaluronate, collagen stimulant, A-type botulinum toxin, implantation line, energy equipment. Valuation:Total market capitalization of $74.68 billion, P/E ratio of 4.3, TTM P/E ratio of 31.89, lower than the historical time 38%, valuation is moderate. 5.Hohai Health Department Introduction: A high-tech biomedical enterprise focusing on the research and development, production and sales of medical biomaterials. Products:Ophthalmic products, medical cosmetic and wound care products, anti-adhesion and hemostatic products. Valuation:Total market capitalization of 14.64 billion, P/E ratio of 2.63, TTM P/E ratio of 46.3, lower than the historical time 87%, valuation is low. 6. Ogilvy medical supplies company Introduction: medical dressings and other disposable medical consumables in the field of one of the few companies with a complete industrial chain. Products:The company's products cover wound care, surgery, infection prevention, medical combination packs, home care five series, some of the products are used in neurosurgery and other advanced areas. Valuation: total market capitalization of 7.726 billion, P/E ratio of 2.66, TTM P/E ratio of 16.35, lower than the historical time 87%, valuation is low. 7.Lancel Introduction:The company holds Milan Berry Lou, skin purification medical beauty, high to rise medical beauty three domestic medical beauty brands, and strategic investment in South Korea's famous medical beauty services group DMG. Products:Women's coat, women's pants, women's skirts, women's coats, baby clothes, baby products, surgical medical beauty, non-surgical medical beauty, consulting services. Valuation:Total market capitalization of 13.34 billion, P/E ratio of 4.54, TTM P/E ratio of 128.99, 25% below the historical time, valuation is high. 8.Baofenix (woman's name) Profile:The company's subsidiary Kunming Weinuo is mainly engaged in medical cosmetic services, including laser, micro-needling and other beauty services. Products:Creams, skin lotions, masks, essences, emulsions and other skin care products, isolation creams, BB creams, makeup remover and other makeup products. Valuation:Total market capitalization of 78.11 billion, P/E ratio of 15.94, TTM P/E ratio of 83.96, lower than 90% of the historical time, valuation is extremely low. 9.Shui Yang shares Introduction: HPH is the company's new light medical beauty brand, currently mainly in Tmall, Ji Yun and other channels, the main body of the operation is Yu Jiahui Holdings. Products: Masks, water creams, color cosmetics, personal care, cleaning and other cosmetics. Valuation:Total market capitalization of 6.619 billion, P/E ratio of 3.9, TTM P/E ratio of 28.74, lower than 80% of the historical time, valuation is low. 10.Naturalization of Fang La Introduction:The company's main business is toiletries, skin care and color cosmetics products. Products:Cream, conditioner, body wash, shampoo, soap, gel water, gel cream Valuation:Total market capitalization of 3.003 billion, P/E ratio of 1.62, TTM P/E ratio of 60.38, lower than the historical time 86%, valuation is low. /feed/18d8bc3eb13533faafa078427c062d1540345bac.png?token=b2748af42819a67d2e121f27c688f261